VERACYTE, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Veracyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Veracyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $15.2M.
  • Veracyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.27M, a 81.4% increase year-over-year.
  • Veracyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$74.4M, a 104% decline from 2022.
  • Veracyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.6M, a 51.6% increase from 2021.
  • Veracyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$75.6M, a 116% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.27M $15.2M +$44.8M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$54M $5.73M +$14.1M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$68.2M -$1.86M +$6.23M +77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$74.4M -$28.3M -$24.4M -636% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$50M -$29.6M -$20.9M -240% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$29.1M -$8.4M +$1.13M +11.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$30.2M -$8.09M +$6.37M +44.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$36.6M -$3.84M +$6.68M +63.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$43.2M -$8.72M +$5.41M +38.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$48.7M -$9.53M -$494K -5.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$48.2M -$14.5M +$27.4M +65.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$75.6M -$10.5M -$2.48M -30.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$73.1M -$14.1M -$10M -243% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$63.1M -$9.04M +$1.99M +18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$65.1M -$41.9M -$30.2M -257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$34.9M -$8.04M -$586K -7.86% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-22
Q3 2020 -$34.3M -$4.12M -$3.39M -465% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$30.9M -$11M -$8.53M -342% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$22.4M -$11.7M -$9.8M -511% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$12.6M -$7.46M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-22
Q3 2019 -$730K Jul 1, 2019 Sep 30, 2019 10-K 2021-02-22
Q2 2019 -$2.49M Apr 1, 2019 Jun 30, 2019 10-K 2021-02-22
Q1 2019 -$1.92M Jan 1, 2019 Mar 31, 2019 10-K 2021-02-22
Q4 2013 -$25.6M -$5.89M -$1.06M -21.8% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-20
Q3 2013 -$24.5M -$6.3M -$1.37M -27.6% Jul 1, 2013 Sep 30, 2013 10-K 2014-03-20
Q2 2013 -$23.2M -$6.49M -$1.86M -40.3% Apr 1, 2013 Jun 30, 2013 10-K 2014-03-20
Q1 2013 -$21.3M -$6.9M -$2.65M -62.3% Jan 1, 2013 Mar 31, 2013 10-K 2014-03-20
Q4 2012 -$18.6M -$4.84M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 -$4.94M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-20
Q2 2012 -$4.63M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-20
Q1 2012 -$4.25M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.